- ICH GCP
- Amerikanska kliniska prövningsregistret
- Klinisk prövning NCT07673081
Real-World Effectiveness of RSV Vaccines Among Adults Using Target Trial Emulation in Epic Cosmos
Studieöversikt
Status
Betingelser
Studietyp
Inskrivning (Beräknad)
Kontakter och platser
Studieorter
-
-
New York
-
New York, New York, Förenta staterna, 10001
- Pfizer
-
-
Deltagandekriterier
Urvalskriterier
Åldrar som är berättigade till studier
- Vuxen
- Äldre vuxen
Tar emot friska volontärer
Testmetod
Studera befolkning
Beskrivning
Inclusion: Vaccinated Cohort
Patients must meet all the following inclusion criteria to be eligible for inclusion in the vaccinated cohort:
Adults meet the age criteria at the index date. Non-pregnant at the index date. Have at least one clinical encounter recorded in Epic Cosmos database during the 12 months prior to the index date.
Have a documented administration of ABRYSVO® (or AREXVY®,mRESVIA® in the later phase) in Epic Cosmos on or after August 2023.
The index date for vaccinated individuals will be defined as the date of RSV vaccination.
Unvaccinated Cohort
Patients must meet all the following inclusion criteria to be eligible for inclusion in the unvaccinated cohort:
Adults meet the age criteria at the index date. Non-pregnant at the index date. Have at least one clinical encounter recorded in Epic Cosmos database during the 12 months prior to the index date.
Have no documented receipt of any RSV vaccine in Epic Cosmos on or prior to the trial start date.
The index date for unvaccinated individuals will be defined as the start date of each sequential trial (e.g., 1st date of each month) in which they met eligibility criteria.
Exclusion:
Vaccinated Cohort
Patients meeting any of the following criteria will not be included in the vaccinated cohort:
Individual with receipt of any RSV vaccine in Epic Cosmos prior to the trial start date, as defined above (applicable to all analyses except for the analysis of recipients of multiple doses).
Non-US residents. Unvaccinated Cohort
Patients meeting any of the following criteria will not be included in the unvaccinated cohort:
Individual with receipt of any RSV vaccine in Epic Cosmos on or prior to the trial start date, as defined above.
Non-US residents. Patients must meet all the inclusion criteria and none of the exclusion criteria to meet eligibility requirements.
Studieplan
Hur är studien utformad?
Designdetaljer
Kohorter och interventioner
Grupp / Kohort |
|---|
|
Vaccinated group
Individuals with documented receipt of an RSV vaccine in EHR data.
Vaccines included: ABRYSVO® (Pfizer),AREXVY® (GSK), mRESVIA® (Moderna)
|
|
Unvaccinated comparator group:
Individuals not yet vaccinated at cohort entry, but otherwise eligible
|
Vad mäter studien?
Primära resultatmått
Resultatmått |
Tidsram |
|---|---|
|
Incidence of RSV-related Acute Respiratory Infection (ARI) hospitalization
Tidsram: up to 3 years
|
up to 3 years
|
|
Incidence of RSV-related Lower Respiratory Tract Disease (LRTD) hospitalization
Tidsram: up to 3 years
|
up to 3 years
|
Sekundära resultatmått
Resultatmått |
Åtgärdsbeskrivning |
Tidsram |
|---|---|---|
|
Incidence of RSV-related outcomes
Tidsram: up to 3 years
|
ARI/LRTD non-inpatient encounter, ARI/LRTD severe outcome, ARI/LRTD critical outcome, CV events with different care settings, thromboembolic event with different care settings, asthma exacerbation with different care settings, COPD exacerbation with different care settings, and pneumonia with different care settings.
|
up to 3 years
|
|
Incidence of All-cause outcomes
Tidsram: up to 3 years
|
all-cause ARI/LRTD encounter with different care settings, severe outcome, critical outcome, CV events with different care settings, thromboembolic event with different care settings, asthma exacerbation with different care settings, COPD exacerbation with different care settings, pneumonia with different care settings, and dementia (new onset).
|
up to 3 years
|
Samarbetspartners och utredare
Studieavstämningsdatum
Studera stora datum
Studiestart (Faktisk)
Primärt slutförande (Beräknad)
Avslutad studie (Beräknad)
Studieregistreringsdatum
Först inskickad
Först inskickad som uppfyllde QC-kriterierna
Första postat (Faktisk)
Uppdateringar av studier
Senaste uppdatering publicerad (Faktisk)
Senaste inskickade uppdateringen som uppfyllde QC-kriterierna
Senast verifierad
Mer information
Termer relaterade till denna studie
Andra studie-ID-nummer
- C3671094
Plan för individuella deltagardata (IPD)
Planerar du att dela individuella deltagardata (IPD)?
IPD-planbeskrivning
Läkemedels- och apparatinformation, studiedokument
Studerar en amerikansk FDA-reglerad läkemedelsprodukt
Studerar en amerikansk FDA-reglerad produktprodukt
produkt tillverkad i och exporterad från U.S.A.
Denna information hämtades direkt från webbplatsen clinicaltrials.gov utan några ändringar. Om du har några önskemål om att ändra, ta bort eller uppdatera dina studieuppgifter, vänligen kontakta register@clinicaltrials.gov. Så snart en ändring har implementerats på clinicaltrials.gov, kommer denna att uppdateras automatiskt även på vår webbplats .